Skin : Impact Factor & More
eISSN: 2574-1624
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Skin Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | National Society for Cutaneous Medicine |
| Language | English |
| Publication Time | 4 |
| Editorial Review Process | Editorial review,Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 4 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Skin ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Skin
Patient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
- 1 May 2026
- Skin (Milwood, N.Y.)
Gamer’s Dermatitis: When Victory Comes with a Rash
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Safety of Intramuscular Triamcinolone Injections for Hidradenitis Suppurativa Flares: Findings from a Retrospective Cohort Study
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Eruptive Cutaneous Metastatic Leiomyosarcoma
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Once-daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A Prospective, Non-Interventional Study of the Safety and Effectiveness of Cemiplimab in Immunocompromised/Immunosuppressed Patients With Advanced Cutaneous Squamous Cell Carcinoma at 2 Years’ Follow-Up
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Patient Characteristics and Treatment Approaches in Delusional Infestation Across Two Medical Centers: A Retrospective Study
- 1 May 2026
- Skin (Milwood, N.Y.)
Gamer’s Dermatitis: When Victory Comes with a Rash
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Safety of Intramuscular Triamcinolone Injections for Hidradenitis Suppurativa Flares: Findings from a Retrospective Cohort Study
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Eruptive Cutaneous Metastatic Leiomyosarcoma
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
Once-daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A Prospective, Non-Interventional Study of the Safety and Effectiveness of Cemiplimab in Immunocompromised/Immunosuppressed Patients With Advanced Cutaneous Squamous Cell Carcinoma at 2 Years’ Follow-Up
- 10 Mar 2026
- SKIN The Journal of Cutaneous Medicine
FAQs on Skin
How many articles did Skin publish last year? 
Who is the publisher of Skin?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations